BioStock: Age Labs on the collaboration with Lipum: “We aim to bring precision medicine to RA”
Lipum and the Norwegian diagnostics company Age Labs are collaborating to develop a method for predicting which patients with rheumatoid arthritis will respond best to Lipum’s drug candidate, SOL-116. The project has a budget of approximately EUR 1.9 million and is funded at 50 per cent by Eurostars, with support from Vinnova and the Research Council of Norway.
– The positive decision from Eurostars enables us to carry out this project together with Age Labs, with the goal of enabling effective and personalised treatment, says CEO Ola Sandborgh.
Read the full article at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se